학술논문
The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma
Document Type
Article
Author
Source
In: Oncogene . (Oncogene, 1 April 2018, 37(14):1830-1844)
Subject
Language
English
ISSN
14765594
09509232
09509232